Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase
Authors:
- 1 November 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (11) , 2083-2089
Abstract
Background— The HDL-associated enzyme paraoxonase protects LDLs from oxidative stress. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) appear to favorably influence the atherosclerotic process by different mechanisms. The present study examined the influence of simvastatin on paraoxonase expression and serum paraoxonase levels. Methods and Results— Simvastatin upregulated in a dose-dependent manner the activity of the promoter of the paraoxonase gene in expression cassettes transfected into HepG2 cells. Upregulation could be blocked by mevalonate and other intermediates of the cholesterol biosynthetic pathway. Simvastatin increased nuclear factors, notably sterol regulatory element–binding protein-2, capable of binding to the paraoxonase promoter; this was also blocked by mevalonate. Sterol regulatory element–binding protein-2 upregulated promoter activity in vitro. Patients treated with statin showed a significant increase in serum concentrations and activities of paraoxonase. Conclusions— The data indicate that simvastatin can modulate expression in vitro of the antioxidant enzyme paraoxonase and is associated with increased serum paraoxonase concentration and activity. It is consistent with effects of simvastatin treatment, which have the potential to influence beneficially antiatherogenic mechanisms at the HDL level. The study provides evidence for 1 molecular mechanism by which paraoxonase gene expression could be regulated.Keywords
This publication has 29 references indexed in Scilit:
- Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position −107, implicating the Sp1 transcription factorBiochemical Journal, 2003
- Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic MiceCirculation, 2002
- Regulation of gene expression by SREBP and SCAPBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart diseaseAtherosclerosis, 2000
- LetterJACC, 2000
- Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic PathwayAnnual Review of Biochemistry, 1999
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- High density lipoprotein and lipoprotein oxidationCurrent Opinion in Lipidology, 1996
- High density lipoproteins and coronary heart diseaseAtherosclerosis, 1996
- Cooperation by Sterol Regulatory Element-binding Protein and Sp1 in Sterol Regulation of Low Density Lipoprotein Receptor GeneJournal of Biological Chemistry, 1995